Connect Biopharma Holdings (CNTB) FCF Margin (2024 - 2026)

Connect Biopharma Holdings has disclosed FCF Margin across 3 years of filings, most recently posting 575.18% for Q2 2026.

• In Q2 2026, FCF Margin rose 2628732.0% year-over-year to 575.18%; the TTM figure through Jun 2026 stood at 2058.96% (down 8847.0% YoY), while the FY2025 annual figure was 80954.69%, down 8086111.0% from the prior year.
• FCF Margin came in at 575.18% for Q2 2026 at Connect Biopharma Holdings, up from 9469.23% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 377.08% in Q4 2024 to a low of 109000.0% in Q3 2025.
• Average FCF Margin over 3 years is 24560.51%, with a median of 5274.16% recorded in 2026.
• Year-over-year, FCF Margin plunged 10792092 bps in 2025 and jumped 2628732 bps in 2026.
• Over 3 years, FCF Margin stood at 377.08% in 2024, then tumbled by 28807 bps to 109000.0% in 2025, then soared by 99 bps to 575.18% in 2026.
• Per Business Quant data, the three most recent FCF Margin figures were 575.18% in Q2 2026, 9469.23% in Q1 2026, and 109000.0% in Q3 2025.